RenovoRx (NasdaqCM:RNXT) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsJustin Walsh - Director of HealthcareMark Voll - CFORamtin Agah - Executive Chairman and FounderShaun Bagai - CEOValter Pinto - Managing DirectorConference Call ParticipantsEdward Woo - Director of Research and Senior AnalystScott Henry - Managing Director and Senior Research AnalystSwayampakula Ramakanth - Managing Director of Equity Research and Senior Healthcare AnalystOperatorGood afternoon. I'll be your confer ...

Standard Lithium (NYSEAM:SLI) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsAndy Robinson - President, COO, and DirectorAnthony Taglieri - Senior Equity Research AssociateDaniel Rosen - VP of Strategy and Investor RelationsDavid Park - CEO and DirectorEric Boyes - Managing DirectorMax Yerrill - VP of Critical Minerals ResearchNoel Parks - Managing DirectorSalah Gamoudi - CFOConference Call ParticipantsJoseph Reagor - Managing Director and Senior Research AnalystTheo Genzebu - Associat ...

Spruce Power (NYSE:SPRU) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsChris Hayes - CEOJulia Cassari - Head of Corporate Development and Investor RelationsTom Cimino - CFOWill Hamilton - Partner and Portfolio Manager of Kestrel Phoenix FundOperatorI'd like to welcome everyone to the Spruce Power fourth quarter 2025 earnings results conference call. All lines have been placed on mute to prevent any background noise. If you'd like to ask a question during the question and answer sessio ...

RenovoRx (NasdaqCM:RNXT) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsJustin Walsh - Director of HealthcareMark Voll - CFORamtin Agah - Executive Chairman and FounderShaun Bagai - CEOValter Pinto - Managing DirectorConference Call ParticipantsEdward Woo - Director of Research and Senior AnalystScott Henry - Managing Director and Senior Research AnalystSwayampakula Ramakanth - Managing Director of Equity Research and Senior Healthcare AnalystOperatorGood afternoon. I'll be your confer ...

Lantern Pharma (NasdaqCM:LTRN) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsDavid Margrave - CFOPanna Sharma - President and CEOOperatorThe webcast replay of the conference call and webinar will be available on Lantern's website. On today's webcast, we have Lantern Pharma CEO Panna Sharma and CFO David Margrave. Panna will start things off with introductions and an overview of Lantern's strategy and business model and highlight recent achievements in our operations, after which David ...

Sangamo Therapeutics (NasdaqCM:SGMO) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCassie Yuan - Biotechnology Equity Research AssociateJames Heaney - Equity Research SVPLouise Wilkie - Head of Investor Relations and Corporate CommunicationsLuis Santos - Senior Equity Research AssociateNathalie Dubois-Stringfellow - Chief Development OfficerSandy Macrae - CEOOperatorGood afternoon, and welcome to the Sangamo Therapeutics fourth quarter and full year 2025 teleconference call. Please be ...

Sangamo Therapeutics (NasdaqCM:SGMO) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCassie Yuan - Biotechnology Equity Research AssociateJames Heaney - Equity Research AssociateLouise Wilkie - Head of Investor Relations and Corporate CommunicationsLuis Santos - Senior Equity Research AssociateNathalie Dubois-Stringfellow - Chief Development OfficerSandy Macrae - CEOOperatorGood afternoon, and welcome to the Sangamo Therapeutics fourth quarter and full year 2025 teleconference call. Ple ...

Intellinetics (NYSEAM:INLX) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsAlison Forsythe - President and CEOJoe Spain - CFORoger Grabner - Director of MarketingOperatorGood evening, and welcome to the Intellinetics fourth quarter and full year 2025 earnings conference call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. You may be placed in the question queue at any time by pressing star one on your telephone ...

INmune Bio (NasdaqCM:INMB) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCJ Barnum - Head of NeuroscienceCory Ellspermann - Interim CFODaniel Carlson - Head of Investor RelationsDavid Moss - CEO and Co-FounderElemer Piros - Managing DirectorMark Lowdell - Chief Scientific Officer and Co-FounderOperatorGreetings, and welcome to the INmune Bio's 2025 fourth quarter and year-end earnings call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of t ...

Solana Company (NasdaqCM:HSDT) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCosmo Jiang - General PartnerJeff Mathiesen - CFOJoseph Chee - Executive ChairmanSerena Jassy - Investor RelationsConference Call ParticipantsBill Papanastasiou - Senior Research Analyst, Digital AssetsFedor Shabalin - Research AnalystMatthew Galinko - Senior Equity Research AnalystOperatorPlease be advised that today's conference is being recorded. I would now like to hand the conference over to your first s ...